1) Endometriosis
[英][,endəu,mi:tri'əusis] [美][,ɛndo,mitrɪ'osɪs]
子宫内膜内异症
1.
S100A4 expression in the eutopic and ectopic endometria from women with and without endometriosis
S100A4在子宫内膜内异症患者在位、异位子宫内膜及正常人子宫内膜组织中的表达
2) endometriosis
[英][,endəu,mi:tri'əusis] [美][,ɛndo,mitrɪ'osɪs]
子宫内膜异位症
1.
Expression of angiopoietin-1 and-2 in endometriosis and adenomyosis;
Ang-1和Ang-2在子宫内膜异位症及子宫腺肌病中的表达
2.
Comparision of Therapeutical Effect of Gestrinone and desogestrel-chip ethinglestradiol on Endometriosis;
孕三烯酮与去氧孕烯炔雌醇片治疗子宫内膜异位症的疗效比较
3.
The effects of TNF-α and sTNFRⅠ on stormal cells of endometriosis;
TNF-α及sTNFRⅠ对子宫内膜异位症在位内膜基质细胞的作用
3) endometriosis(EMs)
子宫内膜异位症
1.
Objective To explore relationship between intron 1 and codon 10 single nucleotide polymorphisms(SNPs) of estrogen receptor-α(ER-α)and clinical characteristics of endometriosis(EMs).
目的探讨雌激素受体α基因内含子1和编码子10的单核苷酸多态性与子宫内膜异位症(简称内异症)发病及临床特性的关系。
2.
Objective:To evaluate the molecular mechanisms by measuring the gene expression of Survivin and Cox-2 which occur in patients with endometriosis(EMS) and to investigate their effects on the initiation and maintenance of EMS.
目的:通过对临床子宫内膜异位症(endomotriosis,EMS)患者异位内膜及在位内膜Survivin mRNA及Cox-2mRNA表达测定,探讨Survivin及Cox-2在EMS发病及发展中的分子生物学机制及其两者的相关性。
3.
Objective To investigate expression of keratinocyte growth factor(KGF) and change in microvessel density(MVD) in eutopic and ectopic endometria of women with endometriosis(EMs) and their correlation with clinical staging and menstrual cycle of the women.
目的研究角质细胞生长因子及微血管密度在子宫内膜异位症患者卵巢异位组织、在位内膜中的变化及其表达与患者的临床分期及月经周期的关系。
4) endometriosis (EMS)
子宫内膜异位症
1.
Experimental research of cellular and humoral immunity in endometriosis (EMS) treated by principle of promoting blood circulation and removing blood stasis, softening hardness and resolving hard masses;
活血化瘀软坚散结法对子宫内膜异位症细胞免疫和体液免疫功能影响的实验研究
2.
Objective To evaluate the molecular mechanism by measuring the gene expression of Survivin,Bcl-2 and Cox-2 in patients with endometriosis (EMS) and investigate their effects on the initiation and maintenance of endometriosis.
目的通过对临床子宫内膜异位症(endometriosis,EMS)患者异位内膜及在位内膜survivin mRNA,bcl-2 mRNA及cox-2 mRNA表达的测定,探讨Survivin,Bcl-2及Cox-2在子宫内膜异位症发病及发展中的分子生物学机制及其三者的相关性。
5) cervical endometriosis
宫颈子宫内膜异位症
1.
Prevention of oral contraceptive in cervical endometriosis after cervical microwave therapy;
避孕药在预防宫颈微波术后宫颈子宫内膜异位症中的应用
6) Endometriosis/compl
子宫内膜异位症/并发症
补充资料：月经期子宫内膜
月经期子宫内膜
在月经周期的第1～4天。此时因黄体萎缩，体内雌、孕激素水平下降，内膜的腺体缩小变性，腺细胞的分泌功能减退。间质的基质降解，水肿消减并有白细胞浸润，内膜的总厚度减少约1/4或更多；螺旋动脉受压缩，血液循环障碍加剧，继而小动脉出现节段性收缩和阵发性痉挛，引起血管壁本身破裂、出血和内膜组织缺血、缺氧、坏死、脱落。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条